This is a contrast between Provention Bio Inc. (NASDAQ:PRVB) and Intec Pharma Ltd. (NASDAQ:NTEC) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other.
Earnings and Valuation
Table 1 shows the top-line revenue, earnings per share and valuation for Provention Bio Inc. and Intec Pharma Ltd.
Table 2 demonstrates the return on assets, return on equity and net margins of Provention Bio Inc. and Intec Pharma Ltd.
Insider Institutional Ownership
Roughly 6.7% of Provention Bio Inc. shares are owned by institutional investors while 40.62% of Intec Pharma Ltd. are owned by institutional investors. 31% are Provention Bio Inc.’s share owned by insiders. Competitively, Intec Pharma Ltd. has 11.4% of it’s share owned by insiders.
In this table we show the Weekly, Monthly, Quarterly,